Medical Communications

Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …

Following the controversy of Mylan’s price increases to its EpiPen (epinephrine) auto-injector, the company’s CEO Heather Bresch is due to …

GlaxoSmithKline’s shingles vaccine Shingrix has topped rival MSD treatment Zostavax as it is shown to remain effective in elderly patients …

The European Commission has approved the use of Eisai’s Kisplyx (lenvatinib) for the treatment of renal cell carcinoma (RCC) following …

Clinical research organisation ClinTec has announced the expansion of its US management team with the selection of Rick Farris as …

As part of the news that French drugmaker Sanofi and Google parent Alphabet’s life sciences firm Verily are to join …

Gilead Sciences has hired Rogers Luo as vice president and general manager of commercial operations in China. Luo formerly served …

Cambridge-based antibodies-to-medicines company Kymab has announced publication of research testing the first step in the effort to develop effective vaccines …

London-based pharma giant GlaxoSmithKline has proposed the creation of a biopreparedness unit to help avert crises like those we have …

It’s Friday, and that means it’s time for another run-down of the biggest stories on Pharmafile.com over the last week. …

Pfizer has pre-emptively sued a number of India-based drug companies including Sun Pharma and Zydus Cadila to block any attempts …

Dechra has announced that the US Food and Drug Administration (FDA) has approved its generic antibiotic. The product will be …

Apple has toughened its stance on health and medical apps that can be bought and downloaded on the iOS App …

Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …

Dr Ole Isacson has been named as the chief scientific officer at Pfizer’s neuroscience research unit. He will continue to …